Description
A secondary bile acid; decreases plasma VLDL and LDL cholesterol levels and reduces fasting glucose levels and atherosclerotic lesion size in LDL receptor knockout mice fed a Western diet at 1.25% in the diet; serum levels are increased in patients with Crohn’s disease or ulcerative colitis
Formal name: (5β)-3α,6α-dihydroxy-cholan-24-oic acid
Synonyms: HDCA|NSC 60672|α-Hyodeoxycholic Acid
Molecular weight: 392.6
CAS: 83-49-8
Purity: ≥90%
Formulation: A crystalline solid
Application|Mass Spectrometry||Product Type|Biochemicals|Lipids|Sterol Lipids||Research Area|Cardiovascular System|Cardiovascular Diseases|Atherosclerosis||Research Area|Cardiovascular System|Lipids & Lipoproteins|Lipoproteins||Research Area|Endocrinology & Metabolism|Bile Acids & Microbiome||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Dyslipidemias||Research Area|Immunology & Inflammation|Gastric Disease|Crohn’s Disease||Research Area|Immunology & Inflammation|Gastric Disease|IBS